Genetron Health
基因泰克
Executive Summary
Genetron Health is a Beijing-based biotech company listed on NASDAQ (GTH) operating in precision medicine and genomics. The company has clear BIOSECURE status, making it potentially attractive for US partnerships compared to other Chinese biotech entities. Limited public information on recent corporate activities and pipeline details suggests either a low profile or potential operational challenges that warrant deeper investigation.
Structure: As a NASDAQ-listed Chinese biotech, Genetron Health likely operates through a Variable Interest Entity (VIE) structure typical for Chinese companies accessing US capital markets. The holding company structure would involve Cayman Islands incorporation with underlying Chinese operating entities, requiring careful due diligence on control mechanisms and regulatory compliance.
BIOSECURE Risk
Company has clear BIOSECURE status and is not designated under BCC categories, indicating lower regulatory risk for US partnerships
Key Exposures:
- •Potential future policy changes
- •Beijing headquarters location
- •Chinese government healthcare data regulations
Mitigation: Clear BIOSECURE status provides current protection, but company should be monitored for any policy developments
BD Intelligence
Therapeutic Areas:
Recent Deals: No recent out-licensing deals identified in available data
Approach: Approach with cautious interest given clear BIOSECURE status, but conduct thorough due diligence on pipeline assets and financial position before advancing discussions
Red Flags
- ⚠Limited public disclosure of corporate activities
- ⚠No visible key personnel information
- ⚠Lack of recent deal flow or partnership announcements
- ⚠Potential operational transparency concerns
Quick Facts
- Key People
- 0
- Subsidiaries
- 0
- CDMO/CRO Subs
- 0
- Genomics Subs
- 0
- Direct BIOSECURE
- 0
- Corp Events
- 0
- Gov-Connected
- 0
- Clinical Trials
- 0
- Publications
- 0
- Drug Molecules
- 0
- Relationships
- 0
Sources & Methodology
Clinical trials data: ClinicalTrials.gov API v2 (0 trials linked to this entity)
SEC BIOSECURE filings: EDGAR EFTS full-text search (850+ filings from 230 companies)
Publications: Europe PMC API (0 publications indexed)
Drug molecules: ChEMBL database (European Bioinformatics Institute)
Financial data: East Money (东方财富) datacenter API / CNINFO (巨潮资讯网)
Corporate structure: Company official filings, HKEX/SSE/SZSE disclosures
Executive profiles: Company official biographies, SEC filings, LinkedIn (where verified)
Data is collected from public sources and updated weekly. Corporate intelligence is verified by a native Mandarin-speaking analyst against Chinese-language primary sources including Tianyancha (天眼查), GSXT (国家企业信用信息公示系统), and CNINFO (巨潮资讯网). This is not financial or legal advice.